Jpmorgan Chase & CO VERTEX PHARMACEUTICALS INC Call Options Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

Call Options

11 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 08, 2024
BUY
N/A
89,600 Added 282.65%
121,300 $0
Q2 2024

Aug 12, 2024
SELL
N/A
-10,300 Reduced 24.52%
31,700 $0
Q1 2024

May 10, 2024
SELL
N/A
-4,000 Reduced 8.7%
42,000 $0
Q4 2023

Feb 12, 2024
BUY
N/A
5,500 Added 13.58%
46,000 $0
Q3 2023

Nov 14, 2023
BUY
N/A
22,400 Added 123.76%
40,500 $0
Q2 2023

Aug 11, 2023
BUY
N/A
11,200 Added 162.32%
18,100 $0
Q1 2023

May 11, 2023
SELL
N/A
-48,200 Reduced 87.48%
6,900 $0
Q4 2022

Feb 13, 2023
BUY
N/A
3,700 Added 7.2%
55,100 $15.9 Million
Q2 2022

Aug 11, 2022
BUY
N/A
36,400 Added 242.67%
51,400 $14.5 Million
Q1 2022

May 11, 2022
BUY
N/A
14,500 Added 2900.0%
15,000 $3.92 Million
Q3 2021

Nov 12, 2021
BUY
N/A
500 New
500 $91,000
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email